As a dual GLP-1RA and GIPRA agonist, tirzepatide's mechanism of action includes reducing appetite and promoting a sensation of completion, which can contribute to weight loss
Erynn Gonzales, PA-C is a board-certified, licensed Physician Assistant who is passionate about helping patients achieve their health and lifestyle goals
This process may be enhanced by administering insulin after a bout of exercise since this is known to increase insulin sensitivity in muscle for up to 2448 h (Dawson and Harrison, 1997)
Additionally, losing excess weight reduces the risk of other health conditions and can improve mobility and balance, potentially reducing the risk of falls
Yes, all of these are subcutaneous injectable medications Patients self-administer the injections, typically once daily (Saxenda) or once weekly (Wegovy, Ozempic, Zepbound) A pharmacist or healthcare provider will teach proper injection technique Dose adjustments should not be done independently